THOUSAND OAKS, Calif., July
23, 2020 /PRNewswire/ -- Amgen today announced the appointment
of Amy E. Miles to its Board of
Directors, effective July 23,
2020. Ms. Miles will serve as a member of the Board's Audit
Committee and Governance and Nominating Committee. Following
the appointment of Ms. Miles, the Board will be composed
of 12 directors, 11 of whom are independent.
"Amy is an accomplished business leader and an experienced
public company board member," said Robert
A. Bradway, chairman and chief executive office of
Amgen. "We are confident that she will add great value to
Amgen and our Board of Directors."
Ms. Miles is the former chair of the board (from 2015 to 2018)
and chief executive officer (from 2009 to 2018) of Regal
Entertainment Group, Inc. Ms. Miles also served as chief executive
officer of Regal Cinemas, Inc. from 2009 to 2018. Prior to
this, Ms. Miles served as executive vice president, chief financial
officer and treasurer, Regal Entertainment Group from 2002 to
2009. She also served as the executive vice president, chief
financial officer and treasurer of Regal Cinemas from 2000 to 2009.
Ms. Miles joined Regal Cinemas in 1999 as Senior Vice
President of Finance. Previously, Ms. Miles was with Deloitte
& Touche, LLP and PricewaterhouseCoopers LLP.
Ms. Miles has been a director of Norfolk Southern Corporation, a
transportation company, since 2014 and serves on the Executive
Committee, Governance and Nominating Committee, and chairs the
Audit Committee. Ms. Miles has been a director of Gap Inc.,
an apparel retail company, since 2020 and serves on the Audit and
Finance Committee. Ms. Miles was a director of National
CineMedia, Inc., a cinema advertising company, from 2011 to
2015. She was a director of Townsquare Media, Inc., a radio,
digital media, entertainment, and digital marketing solutions
company, from 2014 until 2016.
Ms. Miles has been a director of ASM Global, a privately-held
entertainment and venue management company, since 2019. Ms.
Miles serves on the boards of trustees of the University of Tennessee and the Boys and Girls Club
of Eastern Tennessee.
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its biologics manufacturing expertise to strive for solutions that
improve health outcomes and dramatically improve people's lives. A
biotechnology pioneer since 1980, Amgen has grown to be the world's
largest independent biotechnology company, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
CONTACT: Amgen, Thousand
Trish Rowland, 805-447-5631
Megan Fox, 805-447-1423 (media)
Arvind Sood, 805-447-1060
View original content to download